Are we over-treating with checkpoint inhibitors?

Danson, S, Hook, J, Marshall, H orcid.org/0000-0003-0944-0152 et al. (4 more authors) (2019) Are we over-treating with checkpoint inhibitors? British Journal of Cancer, 121 (8). pp. 629-630. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2019. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Immunotherapy; Melanoma
Dates:
  • Accepted: 23 August 2019
  • Published (online): 17 September 2019
  • Published: 15 October 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
FunderGrant number
NIHR National Inst Health ResearchNot Known
Depositing User: Symplectic Publications
Date Deposited: 02 Oct 2019 14:07
Last Modified: 29 Jun 2020 13:35
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1038/s41416-019-0570-y
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)